| Stephen E Connery, MD | |
|
950 N Porter Ave, Suite300, Norman, OK 73071-6400 | |
| (405) 329-0121 | |
| (405) 292-6099 |
| Full Name | Stephen E Connery |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 38 Years |
| Location | 950 N Porter Ave, Norman, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184616070 | NPI | - | NPPES |
| 4077136 | Other | OK | AETNA EDI |
| 100107930A | Medicaid | OK | |
| 080085561 | Other | OK | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD16184 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lifespring Home Health | Norman, OK | Home health agency |
| Accentra Home Health - Western | Norman, OK | Home health agency |
| Loving Care In Home Health Services, Llc | Noble, OK | Home health agency |
| Carter Healthcare Hospice Of Central Oklahoma, Llc | Oklahoma city, OK | Hospice |
| Norman Regional | Norman, OK | Hospital |
| Mercy Hospital Oklahoma City, Inc | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic Oklahoma Communities | 1153468921 | 485 |
News Archive
Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that the Ninth Circuit Court of Appeals has affirmed the 2006 Federal District Court decision that Tyco Healthcare, now Covidien, violated the antitrust laws through anticompetitive business practices related to the sale of its Nellcor pulse oximetry products.
A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer's disease, as well as existing drugs that have therapeutic potential against these targets.
More than 20 million Americans suffer from gastroesophageal reflux disease (GERD), experienced by many as chronic heartburn.
NaturalNano, Inc. announced today that Dr. Michael King, a researcher at Cornell University, has published a new study demonstrating how NaturalNano nanotubes can improve targeting of circulating tumor cells (CTC's). These nanotubes, when added to the surface where cancer cells are attracted, enhance the natural rolling mechanism that Dr. King believes will allow them to be exposed to specific drugs or other therapeutic agents, or isolated for diagnostic and research purposes.
SCYNEXIS, Inc., a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced positive results from the first interim efficacy analysis of the ongoing FURI study.
› Verified 1 days ago
| Entity Name | Mercy Clinic Oklahoma Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386874550 PECOS PAC ID: 1153468921 Enrollment ID: O20091027000755 |
News Archive
Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that the Ninth Circuit Court of Appeals has affirmed the 2006 Federal District Court decision that Tyco Healthcare, now Covidien, violated the antitrust laws through anticompetitive business practices related to the sale of its Nellcor pulse oximetry products.
A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer's disease, as well as existing drugs that have therapeutic potential against these targets.
More than 20 million Americans suffer from gastroesophageal reflux disease (GERD), experienced by many as chronic heartburn.
NaturalNano, Inc. announced today that Dr. Michael King, a researcher at Cornell University, has published a new study demonstrating how NaturalNano nanotubes can improve targeting of circulating tumor cells (CTC's). These nanotubes, when added to the surface where cancer cells are attracted, enhance the natural rolling mechanism that Dr. King believes will allow them to be exposed to specific drugs or other therapeutic agents, or isolated for diagnostic and research purposes.
SCYNEXIS, Inc., a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced positive results from the first interim efficacy analysis of the ongoing FURI study.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen E Connery, MD 950 N Porter Ave, Suite300, Norman, OK 73071-6400 Ph: (405) 329-0121 | Stephen E Connery, MD 950 N Porter Ave, Suite300, Norman, OK 73071-6400 Ph: (405) 329-0121 |
News Archive
Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that the Ninth Circuit Court of Appeals has affirmed the 2006 Federal District Court decision that Tyco Healthcare, now Covidien, violated the antitrust laws through anticompetitive business practices related to the sale of its Nellcor pulse oximetry products.
A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer's disease, as well as existing drugs that have therapeutic potential against these targets.
More than 20 million Americans suffer from gastroesophageal reflux disease (GERD), experienced by many as chronic heartburn.
NaturalNano, Inc. announced today that Dr. Michael King, a researcher at Cornell University, has published a new study demonstrating how NaturalNano nanotubes can improve targeting of circulating tumor cells (CTC's). These nanotubes, when added to the surface where cancer cells are attracted, enhance the natural rolling mechanism that Dr. King believes will allow them to be exposed to specific drugs or other therapeutic agents, or isolated for diagnostic and research purposes.
SCYNEXIS, Inc., a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced positive results from the first interim efficacy analysis of the ongoing FURI study.
› Verified 1 days ago
Ms. Kathleen E Lewis, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1300 Mcgee Dr, Ste 100, Norman, OK 73072 Phone: 405-321-0406 Fax: 405-447-6293 | |
Jayson D Henry, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 E Robinson St, Suite 2200, Norman, OK 73071 Phone: 405-515-0380 Fax: 405-928-2054 | |
Dr. Hieu Chi Nguyen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 24th Ave Nw, Norman, OK 73069 Phone: 405-364-0555 Fax: 405-573-5464 | |
Kevin Q Epperson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 W Tecumseh Rd, Suite 104, Norman, OK 73072 Phone: 405-515-1800 Fax: 405-515-1805 | |
Bobby L Elliott, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 24th Ave Nw, Norman, OK 73069 Phone: 405-573-5400 Fax: 405-573-5406 | |
Dr. Aaron Michael Smathers, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 W Tecumseh Rd Ste 101, Norman, OK 73072 Phone: 405-515-0649 Fax: 405-360-6769 | |
Michelle Deann Barnes, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 950 N Porter Ave, Suite 300, Norman, OK 73071 Phone: 405-329-0121 Fax: 405-292-6099 |